Thyroid disorders are among the most common endocrinopathies encountered during pregnancy.
Pregnancy also presents challenges in interpreting common thyroid function tests. Because TSH levels are generally lower throughout pregnancy, most notably during the first trimester when hCG levels peak,7 physicians should use trimester-specific reference ranges only. For example, in the critical first trimester, the range between the 2.5th and 97.5th percentiles is 0.1 mIU/L to 2.5 mIU/L compared with the nonpregnant range of 0.5 mIU/L to 5 mIU/L.
Multiple assays are available for obtaining serum FT4 levels. These vary widely in accuracy, and many clinicians may be unaware of the assay method their laboratory uses. The most accurate method is a dialysate of serum samples using online extraction/liquid chromatography/tandem mass spectrometry (LC/MS).8 Unfortunately, this method is fairly expensive and not widely available. If LC/MS is not available, experts recommend using method-specific and trimester-specific reference ranges of serum FT4. This makes it difficult to establish 1 specific reference range for FT4. Physicians can adapt the nonpregnant total T4 range of 5 μg/dL to 12 μg/dL or 50 nmol/L to 150 nmol/L for the second and third trimesters by multiplying the range by a factor of 1.5.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More